The majority of pathologies associated with FTLD clinical syndromes include either tau-positive (FTLD-TAU) or TAR DNA-binding protein 43 (TDP-43)-positive (FTLD-TDP) inclusion bodies whilst AD pathology has been found in more than 70% of logopenic PPA cases (61). The gene discussed is TARDBP; the disease is primary progressive aphasia.